Top Markets
Coin of the day
Regenicin, Inc. Regenicin, Inc.

Regenicin, Inc.

RGIN
Rangering i aksjer #41589
Regenicin, Inc. is dedicated to the development and commercialization of... Regenicin, Inc. is dedicated to the development and commercialization of advanced tissue-engineered skin replacement technologies. Its product line features NovaDerm, a sophisticated multi-layered living and cultured skin substitute engineered for treating burn injuries, alongside TempaDerm, which addresses more localized wound areas like ulcers. These innovative solutions aim to rejuvenate the characteristics of healthy human skin, finding application in burn therapy, chronic wound management, and various plastic surgery procedures. Incorporated in 2007 and based in Little Falls, New Jersey, the company was previously known as Windstar, Inc., adopting the Regenicin, Inc. name in July 2010.
Aksjekurs
$0.0001
Sist synkronisert: 2026-08-11
Markedsverdi
$15.35K
Endring (1 dag)
0.00%
Endring (1 år)
0.00%
Land
US
Handel Regenicin, Inc. (RGIN)

Kategori

P/S-forhold for Regenicin, Inc. (RGIN)
P/S-forhold per 2026 TTM: 0
Ifølge Regenicin, Inc. sine siste finansielle rapporter og aksjekurs er selskapets nåværende P/S-forhold (TTM) 0. Ved slutten av 2026 hadde selskapet et P/S-forhold på 0.
P/S-historikk for Regenicin, Inc. fra 2026 til 2026
P/S-forhold ved hvert års slutt
År P/S-forhold Endre
Ikke nok data for de angitte datoene.
P/S-forhold for lignende selskaper eller konkurrenter
Selskap P/S-forhold Forskjell i P/S-forhold Land
9.88 -
US
10.30 -
NL
- -
CH
4.98 -
BE
- -
KR